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(57) ABSTRACT 
A method is provided for forming an autologous graft by 
distending a donor blood vessel and harvesting the distended 
portion of the vessel. Also provided is a device for in vivo 
or in vitro vessel distension. Typically the device is 
implanted, for example using endoscopic techniques, in a 
patient sometime prior to another surgery on that patient 
which includes implanting a vascular graft. The device 
includes a stretching mechanism which is attached to a 
donor blood vessel, means for operating the stretching 
mechanism to cause the vessel to distend, and a controller, 
preferably externally located, for controlling the operating 
means. In a preferred embodiment, the device includes a pair 
of opposed straps, attached to a healthy, small-diameter 
donor blood vessel such as a femoral artery in the leg. The 
straps are displaced from each other over a period of time to 
continuously distend or elongate the donor vessel. The 
distended portion of the donor vessel is excised at the time 
of the bypass surgery. The ends of the donor vessel are then 
sutured end to end to repair the donor vessel, a procedure 
common in vascular repair and generally accomplished 
without complication. The result is a totally autologous, 
living vascular graft. 
32 Claims, 5 Drawing Sheets 
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AUTOLOGOUS VASCULAR GRAFTS 
CREATED BY VESSEL DISTENSION 
2 
Efforts to avoid or minimize the need for vascular grafts 
for repair of otherwise healthy vascular tissue have been 
described. For example, Ruiz-Razura et al., J. Reconstruc-
tive Microsurgery, 10(6):367-373 (1994) and Stark et al., CROSS-REFERENCE TO RELATED 
APPLICATIONS 
Priority is claimed to U.S. provisional application Serial 
No. 60/087,027, filed May 28, 1998. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH 
5 Plastic and Reconstructive Surgery, 80(4):570-578 (1987) 
disclose the use of a round microvascular tissue expander for 
acute arterial elongation to examine the effects on the tissue 
of such acute hyperextension. The expander is a silicone 
balloon that is placed under the vessel to be elongated. The 
Not applicable. 
BACKGROUND OF THE INVENTION 
10 balloon is filled with saline over a very short period of time, 
causing acute stretching and elongation of the vessel. The 
method is purported to be effective for closure of arterial 
defects up to 30 mm without the need for a vein graft. These 
techniques are appropriate for trauma, but are not used for 
The present invention is generally in the area of methods 
and devices to obtain vascular tissue grafts and more spe-
cifically in the area of methods and devices to obtain 
autologous grafts prepared from living vascular tissue. 
15 restoring blood flow in vessels that are occluded, for 
example by disease, which are treated by surgically bypass-
ing the obstruction with a graft. The disclosed methods and 
devices fail to provide an autologous graft or versatile 
substitute. Moreover, the acute stretching may damage the Vascular grafts are commonly used by surgeons to bypass 
obstructions to blood flow caused by the presence of ath-
erosclerotic plaques. Vascular grafts also are used to treat 
other vascular problems. Grafts for bypass are often, but not 
exclusively, used in the coronary arteries, the arteries that 
supply blood to the heart. The materials used to construct a 
25 
vascular graft usually are either synthetic or of biological 
origin, but combinations of synthetic and biological mate-
rials are also under development. The most successful 
biological vascular grafts are autologous saphenous vein or 
mammary artery. Some common synthetic grafts are made 30 
of polytetrafluoroethylene (PTFE) (GORTEX™) or polyes-
20 vessel. 
ter (DACRON™). Autologous grafts have generally been 
used more successfully than synthetic grafts. Autologous 
grafts remain patent (functional) much longer than synthetic 
grafts, but saphenous veins are seldom functional more than 35 five years. The short lifetime of synthetic grafts is especially 
evident with small diameter grafts, as most small diameter 
synthetic grafts occlude within one to two years. 
Mammary artery is the autologous graft of choice, 
because it typically has a longer life than venous grafts (95% 40 
patent at 5 years versus 85% patent at 2 years). Mammary 
arterial tissue, however, is difficult to harvest and typically 
Accordingly, it is an object of the invention to provide a 
method, and devices therefor, for creating an autologous 
blood vessel graft. 
SUMMARY OF THE INVENTION 
A method for creating an autologous vessel graft is 
provided, wherein vessel distension is used to stimulate 
growth of a donor vessel for grafting. Devices useful in the 
method are provided to stretch the vessel rectilinearly, 
curvilinearly, or in a combination thereof The devices can be 
implanted, for example using endoscopic techniques, in a 
bypass surgery patient prior to the bypass surgery, in order 
to create blood vessel grafts. The distended portion of the 
donor vessel is excised at the time of the bypass surgery. The 
ends of the donor vessel are then sutured end to end to repair 
the donor vessel, a procedure common in vascular repair and 
generally accomplished without complication. In an alter-
native embodiment, a section of donor vessel is surgically 
excised from the bypass surgery patient and then distended 
in vitro in a medium for cell growth. The result using either 
approach is a totally autologous, living vascular graft. 
The device preferably includes a stretching mechanism 
which is attached to a donor blood vessel, means for 
is not available in lengths sufficient for effective bypass. 
Moreover, obtaining sufficient venous tissue for repairing an 
occluded artery is problematic. 
In some cases, autologous or homologous saphenous vein 
preserved by freezing or other processes is used. 
45 operating the stretching mechanism to cause the vessel to 
distend, and a controller, preferably externally located, for 
controlling the operating means. In a preferred embodiment 
for rectilinear stretching using vessel attachment points that 
are movable relative to one another, the device includes a 
With people living longer, multiple surgeries are more 
common. At the same time, open heart surgery is becoming 
more routine, aided by the development of new, minimally 
invasive procedures which have dramatically simplified the 
surgery and reduced the recovery time. Development of a 
longer lasting small-diameter vascular graft is the subject of 
much academic and industrial research. One current 
approach is to combine cell culture and biomaterials tech- 55 
nologies to make a living, "tissue engineered" graft. This 
effort, however, is hindered by the requirements of a suc-
cessful graft: it should be self-repairing, non-immunogenic, 
non-toxic, and non-thrombogenic. The graft also should 
have a compliance comparable to the artery being repaired, 
50 pair of opposed straps, which can be attached to a healthy, 
small-diameter donor blood vessel such as a femoral artery 
in the leg. The straps are displaced from each other over a 
period of time to continuously distend or elongate the donor 
vessel. 
In another preferred embodiment, the device includes a 
stretching mechanism having vessel attachment points that 
are fixed relative to one another during the stretching 
operation. For example, the stretching mechanism can 
include a rigid surface having two opposing flexible ends 
60 that are fixedly attached to the donor vessel, and an inflation 
or expansion means, such as a balloon, disposed between the 
flexible ends adjacent the rigid surface. The vessel is dis-
tended in a curvilinear manner as the inflation or expansion 
be easily sutured by a surgeon, and not require any special 
techniques or handling procedures. Grafts having these 
characteristics are difficult to achieve. Despite the substan-
tial effort to date and the potential for significant financial 
reward, academic and industrial investigators have failed to 65 
produce graft materials which have demonstrated efficacy in 
human testing. 
means is inflated or expanded. 
In another preferred embodiment, the device includes a 
stretching mechanism that provides both rectilinear and 
curvilinear stretching. For example, the stretching mecha-
US 6,322,553 Bl 
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nism can include a curved or angled surface having two 
opposing flexible ends that can be fixedly attached to the 
donor vessel, wherein the ends can be drawn towards one 
another. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a plan view of a preferred embodiment of the 
device for vessel distension. 
FIG. 2 is a plan view of a second preferred embodiment 
of the device for vessel distension. 
FIG. 3 is a side elevational view of the distension device 
shown attached to a donor blood vessel. 
FIGS. 4a and 4b are an illustration of a normal and 
stretched blood vessel. 
FIGS. Sa and Sb are perspective views of the front (FIG. 
Sa) and side (FIG. Sb) of a preferred embodiment of the 
device for vessel distension using fixed points of vessel 
attachment. 
FIGS. 6a-6c are diagrams showing vessel distension 
using a preferred embodiment of the device having points of 
vessel attachment that are fixed relative to one another. 
FIGS. 7a and 7b are perspective views of the front (FIG. 
7a) and side (FIG. 7b) of a preferred embodiment of the 
device for both rectilinear and curvilinear vessel distension. 
FIGS. Sa and Sb are diagrams showing vessel distension 
using a preferred embodiment of the device for both recti-
linear and curvilinear vessel distension. 
DETAILED DESCRIPTION OF THE 
INVENTION 
It is known that smooth muscle cells, which dominate the 
media, the major load bearing layer of the arterial wall, 
proliferate and increase their production of extracellular 
matrix in response to mechanical stimulation. It was dis-
covered that this knowledge can be advantageously applied 
to create an autologous graft of appropriate diameter for 
coronary bypass or other vascular graft application using a 
distension device to stimulate angiogenesis. While an 
autologous graft is preferred, the devices and methods 
described herein also can be applied to an artery from a 
transgenic animal genetically engineered to have tissues 
which will not be rejected by humans. The distension device 
can be adapted to operate in vivo or in vitro. 
Distension Device 
The distension device attaches to the donor blood vessel 
4 
that are fixedly attached to the donor blood vessel such as by 
sutures. The opposed straps are displaced away from each 
other over a period of time so that the donor vessel elongates 
as the straps are displaced. After a period of time, such as 
5 when the straps are displaced a pre-determined distance, the 
section of vessel and the device are removed and the ends of 
the donor vessel are sutured together. 
The device straps should be made out of a biocompatible 
material such as a synthetic or natural polymer or metal. The 
10 straps must be able to be attached to the vessel, for example, 
using sutures, staples, or adhesion. Examples of suitable 
material for the straps are polytetrafluoroethylene (PTFE), 
polyester (e.g., DACRON™), nylon (e.g., DELRIN™), 
polysulfone, polypropylene, and polyethylene. The strap 
15 material preferably is doped to render it radio opaque, so that 
the stretching process can be monitored using x-ray tech-
niques. The straps can be wrapped in a material that is then 
attached to the vessel, or they can include perforations or 
holes to accommodate suturing to the vessel. The straps 
20 preferably have a flex strength so as to support the distend-
ing force applied on the stretching mechanism. 
The device includes a means to displace the straps away 
from each other and stretch the vessel. This displacement 
can be accomplished by any of a variety of techniques. For 
25 example, the device can include rods attached to the straps 
that can be moved to push or pull on the straps to slowly 
displace the straps from each other. The rods can be moved, 
for example, by mechanical or hydraulic means. 
30 
b. Operating means 
The device includes means to operate the stretching 
mechanism, preferably including a prime mover and elec-
tronic drivers for the prime mover, both of which are 
preferably implanted. The prime mover can be mechanical, 
such as a linear-motor which operates the stretching mecha-
35 nism to push and/or pull the straps away from each other. A 
rotary motor could also be used to generate the required 
linear motion, using techniques known in the art. 
Alternatively, the prime mover can operate hydraulically. 
Linear or rotary piezo micro-motor devices (actuators) 
40 deliver small step sizes, small forces, have relatively simple 
control electronics and inherent force overload protection. 
Suitable devices are available from a number of vendors, 
including Micro Pulse Systems, Inc. Parameters of the 
operating means include the force applied by the stretching 
45 mechanism, the rate and direction of movement of the 
stretching mechanism, the length of time that the stretching 
mechanism is operated, and the type of stretching applied, 
i.e. continuous, cyclic, or intermittent. 
and distends or stretches it to form an elongated portion. 
Stretching can be continuous, cyclic, or intermittent, and can 50 
occur rectilinearly, curvilinearly, or in a combination thereof 
The stretching can occur between vessel attachment points 
that are movable relative to one other or in fixed positions 
relative to one other. The device can also be adapted for use 
c. Controller 
The controller controls the operating means. In the in vivo 
distension embodiments, the controller can include a micro-
processor that is implanted and that can be activated, 
programmed, or reprogrammed by an externally applied 
magnetic or electromagnetic field. The controller also can be 
activated, programmed, or reprogrammed externally using 
wires that pass through the skin. 
in a process that combines stretching the vessel while the 55 
attachment points are fixed relative to each other with 
stretching the vessel by moving the attachment points away 
from one another. 
A preferred embodiment of the device is shown in FIG. 1. 
Proximal locking strap 10 and distal locking strap 12 are of 
adjustable length appropriate for a good fit around the donor I. Movable Attachment Positions 
The device includes a stretching mechanism which is 
attached by means such as straps or sutures to the donor 
blood vessel, means for operating the stretching mechanism 
to cause the vessel to distend, and a controller for controlling 
the operating means. 
a Stretching Mechanism 
In a preferred embodiment, the distension device stretch-
ing mechanism includes a pair of opposed straps or loops 
60 blood vessel to be distended. Blood vessels range from about 
0.2 to 2 cm in diameter. The locking straps 10, 12, include 
a lace 14, 16, respectively, of a bio-compatible material, 
such as DACRON™, that can be secured to the donor 
vessel, such as by suturing, stapling, or using an adhesive 
65 agent. In a preferred embodiment, the laces are designed 
similarly to the sewing rings of a standard artificial heart 
valve. Alternatively, a layer of a material, such as a fabric or 
US 6,322,553 Bl 
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film, can be attached to the strap so that the vessel can be 
sutured, stapled, or adhered to the material to hold the strap 
to the vessel. In another embodiment, the strap includes 
perforations, holes, or other structural features amenable to 
suturing or stapling, so that the vessel can be sutured or 
stapled directly to the strap. The locking straps have a head 
11, 13 with an internal aperture. Preferably, the straps 10, 12 
include a plurality of teeth (not shown) that, when the free 
end of the lace 14, 16 is inserted through the aperture of the 
head of the strap, engages the head and prevent the free end 
of the lace from becoming disengaged, in a manner similar 
to that of standard pull-ties. Alternatively, the head of the 
strap can engage the strap if the lace 14, 16 does not cover 
the entire strap or if the strap includes securing holes or 
perforations as described above. 
Sliding bearings 18, 20, on straps 10, 12, respectively, and 
stops 22 and 24, respectively, can be either attached to or 
integrally formed (during manufacture) with the straps or 
laces as shown. The bearings and stops are preferably made 
of the same material as the straps, although other biocom-
patible materials can be used. 
A first push/pull rod 26 is fixedly attached to proximal tie 
strap 10 at stop 22. A second push/pull rod 28 is fixedly 
attached to distal tie strap 12 at stop 24. The two push/pull 
rods are preferably initially not fitted to the locking straps 
but are easily assembled on the device in vivo after the 
locking straps are secured around the vessel and sutured or 
otherwise fixed in place. The push/pull rods slide through 
the bearings 18, 20 and engage the stops 22, 24. The 
proximal locking strap 10 including the lace 14, sliding 
bearing 18, stop 22, and the fixedly attached rod 26 form a 
first integrated stretch unit 30. The distal locking strap 12 
including the lace 16, sliding bearing 20, stop 24, and the 
fixedly attached rod 28 form a second integrated stretch unit 
32. Push/pull rods 26, 28 are preferably made of a rigid 
material such as stainless steel or a biocompatible, rigid 
plastic. 
6 
FIG. 2 illustrates a second preferred embodiment 70 of a 
device for vessel distension. The hydraulic embodiment uses 
two miniature, double-acting hydraulic cylinders 72, for 
example made of stainless steel or polymer, through which 
5 hydraulic force is exerted to stretch the blood vessel by 
pushing on strap 10. Double acting hydraulic cylinders 72 
are connected by a hydraulic line 74 into which fluid flows 
to the housing 76 which is a reservoir of a fluid such as saline 
77. Pressure is generated by a piston 78 driven by threaded 
10 rod 80 positioned in a rod support 81 pushing the saline from 
the reservoir out at 83, but may also be generated by means 
external to the body using a catheter through the skin. The 
threaded rod 80 is driven using torque generated by fric-
tional engagement with piezo-actuators 82 or by a miniature 
15 permanent magnet or other suitable motor. Micro Pulse 
Systems Inc. supplies piezo-actuators suitable for use in the 
device. Driver electronics and a power source are indicated 
by 84. Note that while FIG. 2 shows a hydraulic mechanism 
wherein only strap 10 is moved, the hydraulic system may 
20 be readily adapted by one of skill in the art to exert force on 
both strap 10 and strap 12. 
The mechanical or hydraulic stretching mechanism works 
to move the straps apart slowly over a period of time of up 
to several weeks. In one embodiment, the driver may be 
25 pre-programmed to operate autonomously, or the driver may 
be programmed (or reprogrammed) following implantation 
by transcutaneous electromagnetic means, based, for 
example, on x-ray data or other indications of how the 
process is proceeding. The driver may be simply turned on 
30 or off, or may be programmed or reprogrammed by a 
magnetic field sensing device such as a reed switch (relay) 
or by other electronic devices or circuits responsive to 
magnetic or electromagnetic fields. The field is generated by 
using the external driver control to periodically activate an 
35 external source positioned so as to activate the electronic 
driver circuit. The external driver control may be pre-
programmed to provide a stretch of several centimeters over 
about one month. Alternatively, cyclic stretching of increas-
ing peak and mean amplitude may be used. Using piezo 
A wire (or cable) 36, preferably stainless steel, is fixedly 
attached to first push/pull rod 26 at 38 and passes freely 
through a hole 40 in push/pull rod 28. The wire 36 then 
passes freely through the sheath 44 into the prime mover 
housing 46. The prime mover shown is a piezo-actuator or 
other linear motor. Those skilled in the art will recognize that 
several suitable means for pulling the wire or cable are 
known. For example, the wire or cable can be pulled by a 
hydraulic cylinder or actuator powered by an implanted 
pump or by transcutaneous injection of a fluid, such as 
saline. The wire or cable also could be wound on 4 rotating 
reel or attached to a lead screw configured to produce linear 
motion, wherein either are powered by electric or hydraulic 
rotary actuators. FIGS. 1 and 2 show two opposing piezo- 50 
actuators SO contained in the housing 46 which can be 
activated to provide micron-sized step advancement of the 
driven element S3. Wire 36 is attached to driven element S3 
40 actuators, activating the driver can produce incremental 
movements of the mechanical or hydraulic stretching 
mechanism as small as a few microns. The prime mover is 
designed to be force limited so as to preclude over-stretching 
the vessel. Force limitation is inherent if the piezoelectric 
45 actuators are used in either embodiment and, in the case of 
permanent magnetic motors, can be designed into the elec-
tronic driver circuit. 
II. Fixed Attachment Positions 
In stretching an artery to stimulate angiogenesis, the 
blood vessel portion that is beyond the region where the 
stretching apparatus is attached will be relaxed from its 
normal stretched state and could possibly be relaxed to the 
point where it is put in compression, as illustrated in the 
FIGS. 4a and 4b. FIG. 4a shows a blood vessel as it is by a hook S4 or other means so that wire 36 is advanced 
along with driven element S2. Micro Pulse Systems, Inc. 55 
makes micro-actuators that are suitable for the device dis-
closed herein. 
normally stretched in vivo, and FIG. 4b shows how a 
stretching device having points of contact (X) between 
vessel sections A and B and between A and C. The stretching 
device elongates section A while relaxing sections B and C. 
The consequences of this are unknown, but can be avoided 
As the actuator 48 pulls the wire 36, the first integrated 
stretch unit 30 is pushed/pulled towards the actuator 48, in 
the direction of arrow S2. The locking straps are thus 
displaced away from each other. 
60 if the blood vessel is stretched between two fixed points, as 
described herein. 
The device preferably includes an external driver and 
controller, which are not shown in the Figures. In a preferred 
embodiment, the cable can be activated from outside the 
body once the cable is passed through the skin. Mechanisms 65 
outside the body are easier to design and transcutaneous 
catheters and similar conduits are highly developed. 
The fixed point device is described with reference to a 
preferred embodiment shown in FIGS. Sa and Sb. The 
device 90 includes two semicircular or similarly shaped thin, 
yet rigid, plates 92 made of or completely covered by a 
biocompatable material, such as stainless steel, fiber 
composite, or polymer. The plates are separated and con-
US 6,322,553 Bl 
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nected so as to remain parallel by a fiat rectangular strip of 
similar material 94. The ends of the strip 96 are perforated 
or otherwise formed to accept surgical sutures or other 
means (e.g., adhesive) known in the art to secure a blood 
vessel to the strip at its ends. The ends 96 are also flexible 5 
and easily bent, but without breaking, about axis 9S shown. 
The device can be formed from a single appropriately 
shaped thin plate. The area between the plates contains at 
least one inflatable balloon 100, which may be formed from 
silicone, rubber, elastomeric polymers, or any other highly 
deformable biocompatible material. As the balloon is 10 
inflated, it fills the space between the two thin plates without 
significantly changing the spacing between the two plates, 
since the plates and strip are sufficiently rigid to ensure this. 
Inflation of the balloon can be accomplished using at least 
one access port 102, through which a fluid, such as saline, 15 
is injected, for example, through a needle or catheter con-
nected to a syringe or similarly functioning device. The 
inflation process can occur through the skin. The balloon is 
designed and attached to the strip in such a manner that, at 
full inflation, it assumes more or less the shape of the space 20 
between the two plates confining it. 
8 
or following its exc1s10n from the body and subsequent 
placement in a medium for cell growth. As used herein, the 
phrase "medium for cell growth" includes any in vitro 
system for facilitating cell division and growth of vessel 
tissue. For example, the distension device can be attached to 
an excised portion of donor vessel and submerged in a 
medium for cell growth in a temperature controlled con-
tainer. As described in Example 1 below, it has been shown 
that distension in an organ culture (bio-reactor) significantly 
stimulates cell division, and can be simple to control. See, 
for example, U.S. Pat. No. 5,899,936 to Goldstein; U.S. Pat. 
No. 5,879,875, to Wiggins, et al., and U.S. Pat. No. 5,888, 
720 to Mitrani, which describe techniques for organ and 
tissue culture which can be adapted to the methods described 
herein. 
I. Operating the Movable Positions Device 
The method for distending a donor blood vessel includes 
attaching a stretching mechanism to the donor vessel and 
operating the stretching mechanism to stretch the donor 
vessel. Preferably, the method involves using a device 
wherein a pair of straps are fixedly attached to the donor 
vessel and moved away from one another so that the portion 
of the vessel between the straps is distended. The distended 
portion can then be excised and used as a graft. Total 
distensions typically are about 4 to about 6 cm per bypass. 
The rate of vessel distension can readily be optimized by 
those of skill in the art. Distension rates can be linear or 
nonlinear, and may average, for example, about 1 mm/day. 
A preferred embodiment of the method is illustrated in 
FIG. 3, wherein a device is attached to a donor blood vessel 
60. The device can be assembled prior to or at the time of 
implantation. Straps 10, 12 are engaged so as to encircle the 
donor vessel and are then sutured in place. Push/pull rods 30, 
32 are attached to the straps. Wire 36, and the housing 
assembly shaft 44, housing 46 and actuator 4S are attached 
to the device. The prime mover is implanted complete with 
its drive circuit and a minimal power source. As the device 
is operated, the section of vessel 60 between the straps 10, 
12, indicated by 62, stretches. 
II. Operating the Fixed Positions Device 
The device using fixed attachment positions is preferably 
operated as shown in FIGS. 6a-6c. FIGS. 6a-6c show a 
cross-sectional view (a-a) of the device in FIG. 5, at 
increasing degrees of vessel distention occurring with 
An alternative stretching mechanism is provided by 
hydrophilic or chemically reactive synthetic substances 
(e.g., various polymers) or other natural materials (e.g., 
cellulose) known to significantly expand their dry volume 25 
when activated as by exposure to fluid or possibly other 
stimuli (e.g., heat, radiation or various chemical agents). 
Such materials are available in foamed, fiber or other forms, 
any of which may be adapted by one of skill in the art to 
effect the balloon inflation described herein. One or more of 
these materials can be placed inside the balloon and 30 
expanded by the controlled addition of a fluid or chemical 
agent, such as by injection into the balloon, which causes the 
materials to expand, inflating the balloon, in much the same 
way as simply pumping saline or another fluid into the 
balloon as described above. The material could also be 35 
otherwise encapsulated or separated from the stimuli so as to 
control its means and rate of activation. For example, 
expandable material could be provided with a degradable 
coating or other timed-release mechanism, such can be 
adapted from those used in controlled drug delivery. 40 
Alternatively, the balloon can be omitted, and the hydro-
philic or other volume expanding material can simply be 
placed between the two plates in such a manner that expo-
sure to body fluids or another appropriate stimulus causes 
the material to expand and fill the area between plates. 45 increasing inflation/expansion of the balloon/expanding 
material. In operation, the target blood vessel 93 is placed 
between the two plates 92, resting on the uninfiated balloon 
or unexpanded material 100 and secured to the flexible ends 
III. Combination Fixed/Movable Attachment Positions 
An alternative embodiment combines rectilinear and cur-
vilinear stretching. A preferred embodiment is a slightly 
modified version of device 90 shown in FIG. 5. The modi-
fied device is shown in FIGS. 7a and 7b. The device 150 50 
includes strip 152, that is formed much like strip 94, except 
that it is formed in a slightly curved or angled configuration 
and includes at least one, and preferably several, tabs 154, 
positioned at or near the edge of the strip, so as to form a 
channel 156. Strip 152 has flexible ends 15S for attachment 55 
to the vessel. 
A vessel, preferably an artery, is placed in channel 156 
and attached to the strip 152, as for example described for 
strip 94, wherein plates 154 serve to hold the vessel in place. 
The area between the plates contains at least one inflatable 
balloon 160, like balloon 100 described above. Inflation of 
the balloon(s) can be accomplished using at least one access 
port 162, also as described above. 
Method for Distending a Blood Vessel 
The distension device can be adapted to operate in vivo or 
in vitro, that is to distend a portion of a blood vessel in vivo 
96 of the strip, for example by sutures or other suitable 
means (FIG. 6a). As the balloon is inflated (or the material 
expanded), the blood vessel 93 is stretched, between the two 
fixed ends 96 and continues to stretch as the space between 
the two plates is filled (FIGS. 6b and 6c), without the 
possibility of reducing the tension in or compressing the 
blood vessel 93 not between the points of attachment. 
III. Operating the Combination Fixed/Movable Positions 
Device 
The device using the combination of fixed and movable 
attachment positions is preferably operated as shown in 
60 FIGS. Sa-Sb. FIG. Sa shows a blood vessel attached to the 
device before application of the bending force (i.e. before 
distension). FIG. Sb shows the device and vessel following 
application of the bending force, wherein strip end A is 
65 
drawn towards strip end B. 
In operation, the target blood vessel 153 is first placed 
between plates 154, resting on the uninfiated balloon or 
unexpanded material 160 and secured to the flexible ends 
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Integren). The vessels were perfused with the same media 
with the addition of Dextran (5% by weight, MW 282,000 
Sigma). The test and control specimen both were maintained 
at body temperature and subjected to pulsatile flow in the 
158 of the strip, for example by sutures or other suitable 
means. The ends 158 of the strip 152 are then drawn towards 
each other by mechanical or other forces so as to cause strip 
152 to bend or flex, thereby stretching the vessel 153. The 
ends can be drawn towards one another by any suitable 
means, including a mechanical or magnetic force, or by a 
differential expansion effect, for example where the strip 
consists of laminants of materials that contract or expand 
differently from one another when exposed to a stimulus, 
such as heat (thermal expansion) or water (e.g., top layer of 
strip hydrophilic while bottom layer hydrophobic). The 
mechanical means can include, for example, the linear or 
rotary piezo micro-motor devices described herein. As the 
strip 152 is bent, distance C increases and distance AB 
decreases, causing the section beyond either A or B to be 
stretched in a rectilinear manner. 
5 physiological range. The control specimen was restored to 
and maintained at the in-vivo length, which corresponds to 
a stretch ratio of 1.5, for the duration of the experiment. The 
test specimen was stretched an additional 30% to a stretch 
ratio of 1.8 over the first two and one-half days of the five 
10 
day experiment. 
Bromodeoxyuridine ("BRDU") staining was used to com-
pare the number of cells which were dividing in the test and 
control specimens. On the fifth day, the specimens were 
pressure-fixed with formalin and histologic slides prepared 
for cell counting using light microscopy. The BRDU was 
Additionally, balloon 160 is inflated (or the material 
expanded), the blood vessel is stretched, between the two 
ends 158 and continues to stretch as the space between the 
two plates is filled. Thus, the section of blood vessel between 
ends A and B is stretched in a curvilinear manner. The two 
modes of stretching can occur simultaneously, one after 
another in either order, or any combination thereof. 
15 added on day four and the test specimen showed that 
6.8+/-2.8% of the cells were dividing, while only 3.08+/-
2.9% of the cells were dividing in the control specimen. The 
results clearly suggest that axial stretching can be used to 
enhance cell division in blood vessels, and should therefore 
20 be useful in the growing vessel segments for use in creating 
blood vessel grafts. 
Application of the Distension Devices and Methods 
Modifications and variations of the present invention will 
be obvious to those of skill in the art from the foregoing 
detailed description. Such modifications and variations are 
25 intended to come within the scope of the following claims. 
In a preferred embodiment of the in vivo distension 
method, the device is implanted in the patient and vessel 
distension effected over a period of time. Then the site of 
implantation is re-exposed, all or a portion of the vessel 
section (identified as 62 in FIG. 3) is removed, the device is 30 
removed, and the free ends of the donor vessel are sutured 
I claim: 
1. A device for distending a donor blood vessel of a human 
or animal in need thereof, comprising: 
a stretching mechanism attachable directly to the donor 
blood vessel; and 
means for operating the stretching mechanism to cause 
the vessel to extend axially. to each other. The removed section is then ready for use as 
a graft in the patient. 
In a preferred embodiment of the in vitro distension 
method, a portion of donor blood vessel (e.g. shorter than 
that needed for a graft) is surgically excised from the patient 
2. The device of claim 1 wherein the stretching mecha-
nism can stretch the vessel rectilinearly, curvilinearly, or in 
35 a combination thereof. 
in need of the graft, and then the vessel portion is distended 
over a period of time. All or a portion of the distended vessel 
is then ready for use as a graft in the patient. 
The devices and methods of use thereof described herein 40 
are further described by the following non-limiting example. 
3. The device of claim 2 wherein the means for stretching 
the vessel rectilinearly, curvilinearly, or in a combination 
thereof, can be operated simultaneously or one after another 
in either order. 
4. The device of claim 1 wherein the stretching mecha-
nism comprises a pair of opposed straps that can be fixedly 
attached to the donor vessel and moved away from each 
other over a period of time. Example 1 
In Vivo Vessel Stretching to Stimulate Cell Division 
Leung et al., Science 191:475-77 (1976) showed that 
cyclic stretching stimulates synthesis of matrix components 
in arterial smooth muscle cells in-vitro. Subsequent studies 
5. The device of claim 3 wherein the means for operating 
45 the stretching mechanism comprises a prime mover that is 
electronically or hydraulically driven. 
in arterial tissue have been limited to the effects stretching 
on cells attached to a membrane in cell culture (see, for 
example, Birukov, et al., Molecular & Cellular Biochem. 50 
144:131-39 (1995); Costa, et al., FASEB J. 5:A1609-7191 
(1991)) or in a vascular graft construct (Kanda, et al., Cell 
Transplantation 4(6):587-95 (1995)). No known studies, 
however, have analyzed the effect of stretch on cells in intact 
vessel walls. Therefore, a study was made of porcine carotid 55 
arteries in an organ culture system developed by Conklin 
(Conklin, B. Viability of Porcine Common Carotid Arteries 
in a Novel Organ Culture System MS Thesis, Georgia 
Institute of Technology, 1997), in order to determine the 
effect of axial stretching on smooth muscle cell division in 60 
an intact vessel. 
Left and right external carotid arteries were obtained at 
slaughter, one for testing and the other serving as a control. 
Both vessels were immersed in cell culture media containing 
DMEM (Sigma D1152), sodium bicarbonate (3.7 g/L, 65 
Sigma), L-glutamine (2 mM, Sigma), antibiotic-antimycotic 
solution (10 ml/L, Gibco), and calf serum (CS 10%, 
6. The device of claim 4 wherein the stretching mecha-
nism further comprises a pair of push/pull rods each con-
nected to the opposing straps. 
7. The device of claim 1 wherein the stretching mecha-
nism comprises 
a rigid surface having two opposing flexible ends that can 
be fixedly attached to the donor vessel, and 
an inflation or expansion means disposed between the 
flexible ends and adjacent to the rigid surface. 
8. The device of claim 7 wherein the inflation means 
comprises a balloon. 
9. The device of claim 7 further comprising a pair of 
plates projecting from the rigid surface, wherein the plates 
are substantially parallel to each other between the flexible 
ends, so that the inflation or expansion means is disposed 
between the plates. 
10. The device of claim 1 wherein the stretching mecha-
nism comprises 
a curved or angled surface having two opposing flexible 
ends that can be fixedly attached to the donor vessel, 
wherein the ends can be drawn towards one another. 
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11. The device of claim 10 further comprising a plurality 
of tabs projecting from the surface so as to form a channel 
for holding a vessel. 
12. The device of claim 1 wherein all or a portion of the 
device is radioopaque. 
13. The device of claim 1 further comprising a controller 
for controlling the operating means. 
5 
12 
opposing flexible ends that are fixedly attached to the donor 
vessel, and wherein the ends are drawn towards one another 
so that the portion of the vessel between the flexible ends is 
distended. 
25. The method of claim 17 wherein the stretching 
mechanism is operated in an intermittent manner. 
26. The method of claim 17 wherein the stretching 
mechanism is operated in a continuous manner. 14. The device of claim 1 wherein the means for operating 
the stretching mechanism can operate in an intermittent 
manner. 
15. The device of claim 1 wherein the means for operating 
the stretching mechanism can operate in a continuous man-
ner. 
27. The method of claim 12 wherein the stretching 
10 
mechanism is operated in an cyclic manner. 
16. The device of claim 1 wherein the means for operating 
the stretching mechanism can operate in an cyclic manner. 15 
17. A method for distending a donor blood vessel of a 
human or animal in need thereof, comprising the steps: 
attaching a stretching mechanism directly to the donor 
vessel; and 
operating the stretching mechanism to stretch the donor 20 
vessel over a period of time. 
18. The method of claim 17 wherein the stretching occurs 
lil VIVO. 
19. The method of claim 17 wherein the donor vessel is 
excised from the human or animal before attachment of the 25 
stretching mechanism. 
28. A method of forming an autologous vascular graft in 
a human or animal in need thereof, comprising: 
(a) distending a donor blood vessel by use of a method 
comprising 
(i) attaching a stretching mechanism directly to the 
donor vessel, and 
(ii) operating the stretching mechanism gradually or 
repeatedly over a period of time sufficient to stretch 
the donor vessel to a desired length; 
(b) excising the distended portion of the donor vessel; and 
( c) suturing the ends of the donor vessel to repair the 
donor vessel. 
29. The method of claim 28 wherein the device or a 
portion thereof is radioopaque, further comprising taking an 
x-ray to determine the extent of stretching. 
20. The method of claim 17 wherein the vessel is stretched 
rectilinearly, curvilinearly, or in a combination thereof. 
21. The method of claim 20 wherein the vessel is stretched 
rectilinearly, curvilinearly, or in a combination thereof, 
simultaneously or one after another in either order. 
30. The method of claim 28 wherein the device comprises 
a microprocessor comprising programming the micropro-
30 cessor to control the stretching. 
22. The method of claim 17 wherein the stretching 
mechanism comprises a pair of straps that are fixedly 
attached to the donor vessel and moved away from each 
other so that the portion of the vessel between the straps is 35 
distended. 
23. The method of claim 17 wherein the stretching 
mechanism comprises a rigid surface having two opposing 
flexible ends that are fixedly attached to the donor vessel and 
an inflation or expansion means disposed between the flex- 40 
ible ends adjacent the rigid surface, and wherein the inflation 
or expansion means is inflated or expanded so that the 
portion of the vessel between the flexible ends is distended. 
24. The method of claim 17 wherein the stretching 
mechanism comprises a curved or angled surface having two 
31. A method of forming an autologous vascular graft for 
a human or animal in need thereof, comprising: 
(a) excising a donor vessel portion of a blood vessel from 
the human or animal; and 
(b) distending the donor vessel by use of a method 
comprising 
(i) attaching a stretching mechanism directly to the 
donor vessel, and 
(ii) operating the stretching mechanism gradually or 
repeatedly over a period of time sufficient to stretch 
the donor vessel to a desired length. 
32. The method of claim 31 wherein the distending occurs 
in a medium for cell growth. 
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